Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q4 FY23 results · Jan–Mar 2023
Acutaas Chemicals reported revenue from operations of ₹186.38 crore (up 29.8% from Q4 FY22) and net profit of ₹27.20 crore (up 27.8% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.38 | 143.54 | +29.8% | 152.36 | +22.3% |
| Other income | (0.17) | 0.18 | Turned loss | 3.02 | Turned loss |
| Total income | 186.21 | 143.72 | +29.6% | 155.38 | +19.8% |
| Profit before tax | 36.66 | 22.26 | +64.7% | 29.57 | +24.0% |
| Net profit for the period | 27.20 | 21.28 | +27.8% | 22.28 | +22.1% |
| EPS, basic (₹) | 7.46 | 6.22 | +20.0% | 6.28 | +18.9% |
| Net margin (%) | 14.6 | 14.8 | 14.6 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.38 | 143.54 | +29.8% | 152.36 | +22.3% |
| Other income | (0.17) | 0.18 | Turned loss | 3.02 | Turned loss |
| Total income | 186.21 | 143.72 | +29.6% | 155.38 | +19.8% |
| Profit before tax | 36.62 | 22.26 | +64.5% | 29.57 | +23.9% |
| Net profit for the period | 27.16 | 21.28 | +27.6% | 22.28 | +21.9% |
| EPS, basic (₹) | 7.45 | 6.22 | +19.8% | 6.12 | +21.7% |
| Net margin (%) | 14.6 | 14.8 | 14.6 |
Consolidated
- Filed with BSE
- 15 May 2023, 12:17 IST
- Board meeting
- 13 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 May 2023, 12:17 IST
- Board meeting
- 13 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE